Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 31, 2018

SELL
$9.36 - $13.25 $257,633 - $364,706
-27,525 Closed
0 $0
Q1 2018

May 03, 2018

SELL
$8.49 - $11.82 $220,740 - $307,320
-26,000 Reduced 48.58%
27,525 $0
Q4 2017

Jan 17, 2018

SELL
$8.97 - $23.38 $337,272 - $879,088
-37,600 Reduced 41.26%
53,525 $525,000
Q3 2017

Oct 16, 2017

BUY
$15.22 - $20.03 $1.39 Million - $1.83 Million
91,125
91,125 $1.66 Million

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Hamilton Lane Advisors LLC Portfolio

Follow Hamilton Lane Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Lane Advisors LLC with notifications on news.